Genetics Co. Launches JoClone Biotek: A Beacon of Excellence in Biotechnology

Image
01 June 2022

Genetics Co. Launches JoClone Biotek: A Beacon of Excellence in Biotechnology

In a strategic move aimed at furthering its commitment to excellence in biotechnology and genetics, Genetics Co. proudly announced the establishment of JoClone Biotek, a cutting-edge laboratory facility based in Amman, Jordan. Founded in 2022, JoClone Biotek swiftly emerged as a trusted partner for researchers and clients seeking innovative solutions in the realms of biotechnology and genetics.

With a steadfast dedication to quality and expertise, JoClone Biotek quickly set itself apart in the industry. The unique brand name not only reflects its core values but also underscores its specialized proficiency, positioning the lab as a frontrunner in the field.

JoClone Biotek prides itself on offering a diverse range of tailored services to meet the varied needs of its clientele. Equipped with state-of-the-art technology, its research and demo lab provides comprehensive support and training for a myriad of applications and machines, catering to researchers, scientists, and laboratory professionals alike.

The lab's collaborative approach has fostered partnerships across universities, research institutes, and industrial sectors, propelling scientific advancements forward. With a focus on molecular biology applications and immunology research projects, JoClone Biotek is dedicated to pushing the boundaries of innovation in these specialized fields.

As JoClone Biotek continues its rapid expansion, its unwavering dedication to client satisfaction remains paramount. Fueled by passion and driven by innovation, the lab is committed to delivering exceptional service and cutting-edge solutions that empower clients to achieve their scientific objectives.

Join JoClone Biotek on its journey to pioneer the future of biotechnology and genetics, where excellence is not just a goal but a guiding principle. For more information, contact us.

Share It: